Keep up to Date and Stay Informed

Sign up for email alerts to receive company updates including press releases, filings and special announcements straight to your inbox.

Sign me up for:

Latest 10-K

View Latest 10-K

Stock Information

Symbol

NASDAQ: AEMD

Price

Change

Volume

52 week Low/High

Day Low/High

Company Overview

Aethlon Medical develops immunotherapeutic technologies to combat infectious disease and cancer. To augment the body's natural immune defenses, the Aethlon Hemopurifier® reduces the presence of circulating viruses in infected individuals. The technology provides a first-line candidate defense against viruses that are not addressed with proven drug therapies, including natural occurring pandemic threats and agents of bioterrorism. The Hemopurifier® can also be deployed as a strategy to improve the benefit of approved antiviral drug regimens. At present, the Hemopurifier® is being advanced in the United States under an FDA approved clinical study. Aethlon Medical is also investigating the potential use of the Hemopurifier® to reduce the presence of tumor-derived exosomes, which contribute to immune-suppression and the spread of metastasis in cancer patients. Aethlon Medical is also the majority owner of Exosome Sciences, Inc. (ESI), which is focused on the discovery of exosomal biomarkers to diagnose and monitor cancer and neurological disorders, including Alzheimer's disease (AD) and Chronic Traumatic Encephalopathy (CTE). ESI's TauSome™ biomarker is being clinically evaluated as the basis for a blood-based test to identify CTE in living individuals.

Leadership

Our people are our backbone. Touting years of experience in a variety of fields, our leadership team is the source of our success.

IR Contact Information

Aethlon Medical, Inc.

9635 Granite Ridge Drive
Suite 100
San Diego, CA 92123

Tel: 858-459-7800
Fax: 858-272-2738

Investor Relations

CORE IR
John Marco
T: 516-222-2560
johnm@coreir.com

Transfer Agent

Computershare Investor Services
P.O. Box 30170
College Station, TX 77842-3170
T: 781-575-2000
www.computershare.com